Literature DB >> 17145953

Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice.

Virginie Roupie1, Marta Romano, Lei Zhang, Hannelie Korf, May Young Lin, Kees L M C Franken, Tom H M Ottenhoff, Michèl R Klein, Kris Huygen.   

Abstract

Hypoxia and low concentrations of nitric oxide have been reported to upregulate in vitro gene expression of 48 proteins of the dormancy (DosR) regulon of Mycobacterium tuberculosis. These proteins are thought to be essential for the survival of bacteria during persistence in vivo and are targeted by the immune system during latent infection in humans. Here we have analyzed the immunogenicity of eight DosR regulon-encoded antigens by plasmid DNA vaccination of BALB/c and C57BL/6 mice, i.e., Rv1733c, Rv1738, Rv2029c (pfkB), Rv2031c/hspX (acr), Rv2032 (acg), Rv2626c, Rv2627c, and Rv2628. Strong humoral and/or cellular Th1-type (interleukin-2 and gamma interferon) immune responses could be induced against all but one (Rv1738) of these antigens. The strongest Th1 responses were measured following vaccination with DNA encoding Rv2031c and Rv2626c. Using synthetic 20-mer overlapping peptides, 11 immunodominant, predicted major histocompatibility complex class II-restricted epitopes and one K(d)-restricted T-cell epitope could be identified. BALB/c and (B6D2)F(1) mice persistently infected with M. tuberculosis developed immune responses against Rv1733c, Rv2031c, and Rv2626c. These findings have implications for proof-of-concept studies in mice mimicking tuberculosis (TB) latency models and their extrapolation to humans for potential new vaccination strategies against TB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145953      PMCID: PMC1828490          DOI: 10.1128/IAI.01137-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 2.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent.

Authors:  K L Franken; H S Hiemstra; K E van Meijgaarden; Y Subronto; J den Hartigh; T H Ottenhoff; J W Drijfhout
Journal:  Protein Expr Purif       Date:  2000-02       Impact factor: 1.650

Review 4.  Variation in protection by BCG: implications of and for heterologous immunity.

Authors:  P E Fine
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

5.  Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis.

Authors:  A Bandera; A Gori; L Catozzi; A Degli Esposti; G Marchetti; C Molteni; G Ferrario; L Codecasa; V Penati; A Matteelli; F Franzetti
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Authors:  A Tanghe; S D'Souza; V Rosseels; O Denis; T H Ottenhoff; W Dalemans; C Wheeler; K Huygen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Characterization of the major membrane protein of virulent Mycobacterium tuberculosis.

Authors:  B Y Lee; S A Hefta; P J Brennan
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

8.  Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.

Authors:  A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

9.  Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.

Authors:  L A van Pinxteren; J P Cassidy; B H Smedegaard; E M Agger; P Andersen
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

10.  Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells.

Authors:  H M Vordermeier; D P Harris; R Lathigra; E Roman; C Moreno; J Ivanyi
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

View more
  63 in total

Review 1.  Comparative genomics of mycobacteria: some answers, yet more new questions.

Authors:  Marcel A Behr
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

2.  Mucosal vaccination against tuberculosis using inert bioparticles.

Authors:  Rajko Reljic; Laura Sibley; Jen-Min Huang; Ilaria Pepponi; Andreas Hoppe; Huynh A Hong; Simon M Cutting
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

Review 3.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

Review 4.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

5.  Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.

Authors:  K F Siddiqui; M Amir; N Khan; G Rama Krishna; J A Sheikh; K Rajagopal; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2015-06-03       Impact factor: 4.330

6.  Improved Serodiagnostic Sensitivity of Strip Test for Latent Tuberculosis.

Authors:  Songsri Kasempimolporn; Wichit Thaveekarn; Kanyanat Promrungreang; Orawan Khow; Supatsorn Boonchang; Visith Sitprija
Journal:  J Clin Diagn Res       Date:  2017-06-01

7.  Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ).

Authors:  Cecilia S Lindestam Arlehamn; John Sidney; Ryan Henderson; Jason A Greenbaum; Eddie A James; Magdalini Moutaftsi; Rhea Coler; Denise M McKinney; Daniel Park; Randy Taplitz; William W Kwok; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

8.  Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X.

Authors:  In Duk Jung; Sung Jae Shin; Min-Goo Lee; Tae Heung Kang; Hee Dong Han; Seung Jun Lee; Woo Sik Kim; Hong Min Kim; Won Sun Park; Han Wool Kim; Cheol-Heui Yun; Eun Kyung Lee; T-C Wu; Yeong-Min Park
Journal:  J Immunol       Date:  2014-07-02       Impact factor: 5.422

9.  The DosR regulon of M. tuberculosis and antibacterial tolerance.

Authors:  I L Bartek; R Rutherford; V Gruppo; R A Morton; R P Morris; M R Klein; K C Visconti; G J Ryan; G K Schoolnik; A Lenaerts; M I Voskuil
Journal:  Tuberculosis (Edinb)       Date:  2009-07-03       Impact factor: 3.131

10.  Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.

Authors:  Sebastian D Schuck; Henrik Mueller; Frank Kunitz; Albert Neher; Harald Hoffmann; Kees L C M Franken; Dirk Repsilber; Tom H M Ottenhoff; Stefan H E Kaufmann; Marc Jacobsen
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.